Pivotal Phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at [...]
Janet Brown ( December 30, 1964 - September 08, 2019 ) Ms. Janet Marie Brown, MSN, FNP-BC, MSCN, age 54, of Murfreesboro, TN [...]
Blood neurofilament light chain (NfL) levels were significantly lowered following Ocrevus treatment in analyses of Phase III studies in RMS [...]
The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably [...]
Relationships between multiple sclerosis patients and their intimate partners were enhanced when the couple worked together to make [...]
Investigational medicine satralizumab significantly reduces the risk of relapse in pivotal SAkuraStar monotherapy study for neuromyelitis [...]
Study by MS research team links deficits in social cognition with fatigue, depressive symptomatology, and anxiety Date: August 29, [...]
Researchers say genetic makeup is a factor, but so are smoking, obesity, vitamin D, and viral infections. A combination of genetic and [...]